Table 3. Risk factors for ART attrition among Option B+ patients*.
| Adjusted Relative Risk | 95% Confidence Interval | p-value | |
|---|---|---|---|
| Marital status | |||
| Non-married vs. married | 0.97 | (0.83, 1.12) | 0.67 |
| Age | |||
| Each 5-year increase | 0.89 | (0.86, 0.93) | <0.0001 |
| Household characteristics | |||
| Live in same commune as health facility | 0.94 | (0.80, 1.10) | 0.42 |
| 4+ members vs. 1–3 members | 0.98 | (0.82, 1.17) | 0.81 |
| Known HIV+ household member | 0.80 | (0.60, 1.06) | 0.13 |
| Timing of ART start | |||
| Gestational age 30–40 weeks at ART start | 1.20 | (1.02, 1.42) | 0.03 |
| ART start within 7 days of HIV test | 1.19 | (1.05, 1.34) | <0.01 |
| Period of ART initiation (reference = Oct12-Mar13) | |||
| Apr13-Sep13 | 1.06 | (0.95, 1.19) | 0.26 |
| Oct13-Mar14 | 0.97 | (0.81, 1.18) | 0.79 |
| ART starting regimen (reference = TDF+3TC+EFV) | |||
| AZT-3TC-NVP | 1.06 | (0.83, 1.36) | 0.62 |
| AZT-3TC-EFV | 0.88 | (0.72, 1.07) | 0.21 |
| All other | 1.35 | (1.08, 1.69) | <0.01 |
| Clinical status at ART start | |||
| WHO stage III/IV vs. I/II | 0.88 | (0.77, 1.00) | <0.05 |
| BMI (each 1 unit increase) | 0.94 | (0.94, 1.01) | 0.23 |
| Moderate or severe anemia | 1.08 | (0.91, 1.28) | 0.35 |
| Supportive services at ART start | |||
| Treatment buddy named | 0.86 | (0.70, 1.06) | 0.15 |
| Pre-ART counseling provided | 0.74 | (0.62, 0.88) | <0.01 |
| Treatment or prophylaxis for opportunistic infections at ART start | |||
| Tuberculosis-related therapy | 1.03 | (0.87, 1.22) | 0.74 |
| Cotrimoxazole therapy | 0.94 | (0.82, 1.07) | 0.37 |
* Attrition by MSPP definition.